when will i start losing weight on tirzepatide Before and After: Results & Realistic Timeline 2025 GLP-1 Weightloss

Different mechanism, same opportunity

However, when too many cancer cells are created, and/or our immune system cannot keep up, we end up with cancer

Once they see benefits and gain confidence, they transition to injectable for better results

According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 , India's emergence as both a high-growth demand market (19.89% CAGR) and a biosimilar manufacturing hub creates a unique dual role as GLP-1 costs decline through Indian biosimilar production, the addressable patient population in price-sensitive Asian and African markets will expand dramatically, driving the 21.24% volume CAGR through 2031.

and whether some compounding pharmacies are even using semaglutide in their products